CHRISY GAMBRELL: Open Payments
NPI 1487246393 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$142 in 8 payments from 5 companies in 2025. Trend: 2023 $97 · 2024 $32 · 2025 $142
Food & beverage: $142
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $72 |
| Ardelyx, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, IBSRELA, CAPLYTA, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
